Penumbra, Inc Capital Expenditures
Penumbra, Inc (PEN) reported Capital Expenditures of $27.21 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-07-30
- Penumbra, Inc payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $13.54M, a 13.08% decline year-over-year.
- Penumbra, Inc payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $13.67M, a 1.51% increase year-over-year.
- Penumbra, Inc payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $18.43M, a 243.21% increase year-over-year.
- Penumbra, Inc payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $16.25M, a 198.09% increase year-over-year.
- Penumbra, Inc payments to acquire property, plant, and equipment for fiscal 2025 was $63.73M, a 200.86% increase from fiscal 2024.
- Penumbra, Inc payments to acquire property, plant, and equipment for fiscal 2024 was $21.18M, a 39.24% increase from fiscal 2023.
- Penumbra, Inc payments to acquire property, plant, and equipment for fiscal 2023 was $15.21M, a 21.17% decline from fiscal 2022.
- Penumbra, Inc payments to acquire property, plant, and equipment for fiscal 2022 was $19.30M, a 8.89% decline from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $13.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $27.21M 10-Q · filed 2026-07-30 | $45.65M derived: sum of 3 quarters · filed 2026-07-30 | $61.90M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $13.67M 10-Q · filed 2026-05-06 | $32.10M derived: sum of 2 quarters · filed 2026-05-06 | $48.35M derived: sum of 3 quarters · filed 2026-05-06 | $63.93M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $18.43M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $34.68M derived: sum of 2 quarters · filed 2026-02-25 | $50.26M derived: sum of 3 quarters · filed 2026-07-30 | $63.73M 10-K · filed 2026-02-25 |
| 2025-09-30 | $16.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $31.83M derived: sum of 2 quarters · filed 2026-07-30 | $45.30M 10-Q · filed 2025-11-05 | $50.67M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $15.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $29.05M 10-Q · filed 2026-07-30 | $34.42M derived: sum of 3 quarters · filed 2026-07-30 | $39.87M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $13.47M 10-Q · filed 2026-05-06 | $18.84M derived: sum of 2 quarters · filed 2026-05-06 | $24.29M derived: sum of 3 quarters · filed 2026-05-06 | $28.82M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $5.37M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $10.82M derived: sum of 2 quarters · filed 2026-02-25 | $15.36M derived: sum of 3 quarters · filed 2026-02-25 | $21.18M 10-K · filed 2026-02-25 |
| 2024-09-30 | $5.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $9.99M derived: sum of 2 quarters · filed 2025-11-05 | $15.81M 10-Q · filed 2025-11-05 | $19.46M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $4.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | $10.36M 10-Q · filed 2025-07-29 | $14.01M derived: sum of 3 quarters · filed 2026-02-25 | $17.34M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $5.82M 10-Q · filed 2025-04-23 | $9.47M derived: sum of 2 quarters · filed 2026-02-25 | $12.80M derived: sum of 3 quarters · filed 2026-02-25 | $17.14M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | $3.65M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $6.98M derived: sum of 2 quarters · filed 2026-02-25 | $11.32M derived: sum of 3 quarters · filed 2026-02-25 | $15.21M 10-K · filed 2026-02-25 |
| 2023-09-30 | $3.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $7.67M derived: sum of 2 quarters · filed 2024-10-30 | $11.57M 10-Q · filed 2024-10-30 | $15.13M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-06-30 | $4.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-30 | $8.24M 10-Q · filed 2024-07-30 | $11.80M derived: sum of 3 quarters · filed 2025-02-18 | $18.15M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-03-31 | $3.89M 10-Q · filed 2024-05-07 | $7.46M derived: sum of 2 quarters · filed 2025-02-18 | $13.80M derived: sum of 3 quarters · filed 2025-02-18 | $18.23M derived: sum of 4 quarters · filed 2025-02-18 |
| 2022-12-31 | $3.56M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $9.91M derived: sum of 2 quarters · filed 2025-02-18 | $14.34M derived: sum of 3 quarters · filed 2025-02-18 | $19.30M 10-K · filed 2025-02-18 |
| 2022-09-30 | $6.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $10.78M derived: sum of 2 quarters · filed 2023-11-02 | $15.74M 10-Q · filed 2023-11-02 | $23.83M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | $4.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | $9.39M 10-Q · filed 2023-08-01 | $17.48M derived: sum of 3 quarters · filed 2024-02-22 | $23.28M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | $4.96M 10-Q · filed 2023-05-02 | $13.05M derived: sum of 2 quarters · filed 2024-02-22 | $18.85M derived: sum of 3 quarters · filed 2024-02-22 | $22.15M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | $8.09M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $13.89M derived: sum of 2 quarters · filed 2024-02-22 | $17.19M derived: sum of 3 quarters · filed 2024-02-22 | $21.18M 10-K · filed 2024-02-22 |
| 2021-09-30 | $5.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $9.10M derived: sum of 2 quarters · filed 2022-11-03 | $13.09M 10-Q · filed 2022-11-03 | $16.84M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $3.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $7.29M 10-Q · filed 2022-08-05 | $11.04M derived: sum of 3 quarters · filed 2023-02-23 | $15.19M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $3.99M 10-Q · filed 2022-05-03 | $7.74M derived: sum of 2 quarters · filed 2023-02-23 | $11.90M derived: sum of 3 quarters · filed 2023-02-23 | $18.62M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $3.75M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $7.91M derived: sum of 2 quarters · filed 2023-02-23 | $14.63M derived: sum of 3 quarters · filed 2023-02-23 | $24.76M 10-K · filed 2023-02-23 |
| 2020-09-30 | $4.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $10.87M derived: sum of 2 quarters · filed 2021-11-03 | $21.00M 10-Q · filed 2021-11-03 | $28.99M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-06-30 | $6.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $16.85M 10-Q · filed 2021-08-09 | $24.83M derived: sum of 3 quarters · filed 2022-02-22 | $32.75M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-03-31 | $10.13M 10-Q · filed 2021-05-04 | $18.11M derived: sum of 2 quarters · filed 2022-02-22 | $26.03M derived: sum of 3 quarters · filed 2022-02-22 | $29.78M derived: sum of 4 quarters · filed 2022-02-22 |
| 2019-12-31 | $7.98M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $15.90M derived: sum of 2 quarters · filed 2022-02-22 | $19.65M derived: sum of 3 quarters · filed 2022-02-22 | $22.11M 10-K · filed 2022-02-22 |
| 2019-09-30 | $7.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02 | $11.66M derived: sum of 2 quarters · filed 2020-11-02 | $14.13M 10-Q · filed 2020-11-02 | $17.16M derived: sum of 4 quarters · filed 2021-02-23 |
| 2019-06-30 | $3.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-03 | $6.21M 10-Q · filed 2020-08-03 | $9.25M derived: sum of 3 quarters · filed 2021-02-23 | $10.71M derived: sum of 4 quarters · filed 2021-02-23 |
| 2019-03-31 | $2.46M 10-Q · filed 2020-05-07 | $5.50M derived: sum of 2 quarters · filed 2021-02-23 | $6.96M derived: sum of 3 quarters · filed 2021-02-23 | $9.24M derived: sum of 4 quarters · filed 2021-02-23 |
| 2018-12-31 | $3.04M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $4.50M derived: sum of 2 quarters · filed 2021-02-23 | $6.78M derived: sum of 3 quarters · filed 2021-02-23 | $9.60M 10-K · filed 2021-02-23 |
| 2018-09-30 | $1.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $3.74M derived: sum of 2 quarters · filed 2019-11-07 | $6.56M 10-Q · filed 2019-11-07 | $12.29M derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-06-30 | $2.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $5.11M 10-Q · filed 2019-08-06 | $10.83M derived: sum of 3 quarters · filed 2020-02-26 | $12.27M derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-03-31 | $2.82M 10-Q · filed 2019-05-07 | $8.55M derived: sum of 2 quarters · filed 2020-02-26 | $9.99M derived: sum of 3 quarters · filed 2020-02-26 | $12.16M derived: sum of 4 quarters · filed 2020-02-26 |
| 2017-12-31 | $5.73M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | $7.17M derived: sum of 2 quarters · filed 2020-02-26 | $9.34M derived: sum of 3 quarters · filed 2020-02-26 | $12.53M 10-K · filed 2020-02-26 |
| 2017-09-30 | $1.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05 | $3.61M derived: sum of 2 quarters · filed 2018-11-05 | $6.80M 10-Q · filed 2018-11-05 | $13.36M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-06-30 | $2.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $5.36M 10-Q · filed 2018-08-07 | $11.92M derived: sum of 3 quarters · filed 2019-02-26 | $15.30M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-03-31 | $3.19M 10-Q · filed 2018-05-08 | $9.75M derived: sum of 2 quarters · filed 2019-02-26 | $13.13M derived: sum of 3 quarters · filed 2019-02-26 | $15.71M derived: sum of 4 quarters · filed 2019-02-26 |
| 2016-12-31 | $6.56M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $9.94M derived: sum of 2 quarters · filed 2019-02-26 | $12.52M derived: sum of 3 quarters · filed 2019-02-26 | $13.63M 10-K · filed 2019-02-26 |
| 2016-09-30 | $3.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $5.96M derived: sum of 2 quarters · filed 2017-11-07 | $7.08M 10-Q · filed 2017-11-07 | $8.04M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | $2.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $3.69M 10-Q · filed 2017-08-08 | $4.66M derived: sum of 3 quarters · filed 2018-02-27 | $6.10M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | $1.11M 10-Q · filed 2017-05-09 | $2.08M derived: sum of 2 quarters · filed 2018-02-27 | $3.52M derived: sum of 3 quarters · filed 2018-02-27 | $5.29M derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | $967.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $2.40M derived: sum of 2 quarters · filed 2018-02-27 | $4.18M derived: sum of 3 quarters · filed 2018-02-27 | $5.47M 10-K · filed 2018-02-27 |
| 2015-09-30 | $1.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $3.21M derived: sum of 2 quarters · filed 2016-11-03 | $4.51M 10-Q · filed 2016-11-03 | $6.60M derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-06-30 | $1.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $3.07M 10-Q · filed 2016-08-09 | $5.16M derived: sum of 3 quarters · filed 2017-02-28 | |
| 2015-03-31 | $1.30M 10-Q · filed 2016-05-09 | $3.39M derived: sum of 2 quarters · filed 2017-02-28 | ||
| 2014-12-31 | $2.09M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $3.89M 10-K · filed 2017-02-28 | ||
| 2014-09-30 | $1.80M 10-Q · filed 2015-11-12 | |||
| 2013-12-31 | $798.00K 10-K · filed 2016-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |